Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 3, 2020
Bioneer

Applications of In Situ Hybridisation in Research and Disease symposium, May 6-7, 2020, Cambridge (UK)

Applications of In Situ Hybridisation in Research and Disease symposium, May 6-7, 2020, Cambridge (UK)

-
Bioneer
-
February 3, 2020

Bioneer looks forward to the symposium held at Cancer Research UK Institute in Cambridge, which brings together different in situhybridization (ISH) technology users from academia, hospitals and industry.

At the event established, updated as well as brand new ISH applications will be presented and discussed.  Come and take part of how you can use this tool for scientific discoveries and clinical diagnosis.

Dr. Schnack-Nielsen will present during the program’s first session on ‘Insights to Multiplexing Challenges’.

Boye Schnack-Nielsen, heading the molecular histology activities at Bioneer, is one of seven members constituting the Scientific Organising Committee for the symposium. He has vast experience of different in situ hybridization and immunohistochemistry technologies, and is pushing the limits for multiplexing combinations of microRNA, RNA, DNA and proteins.

Take the opportunity to speak with Bioneer and Dr. Schnack-Nielsen at the event in Cambridge, or feel free to contact him by email or calling +45 45 160 444.

To register for the symposium, follow the link.
To download the flyer, press
here.
To learn more about Bioneer’s histology capabilities, press
here.

Last updated:
February 3, 2020

Bioneer

Bioneer A/S is an innovative research-based company providing services within biomedicine and biotechnology.

Click here to read more about us!
Get in touch with us!
Visit us

Bioneer A/S
Kogle Allé 2
DK-2970 Hørsholm
Denmark

Send us mail

Bioneer looks forward to the symposium held at Cancer Research UK Institute in Cambridge, which brings together different in situhybridization (ISH) technology users from academia, hospitals and industry.

At the event established, updated as well as brand new ISH applications will be presented and discussed.  Come and take part of how you can use this tool for scientific discoveries and clinical diagnosis.

Dr. Schnack-Nielsen will present during the program’s first session on ‘Insights to Multiplexing Challenges’.

Boye Schnack-Nielsen, heading the molecular histology activities at Bioneer, is one of seven members constituting the Scientific Organising Committee for the symposium. He has vast experience of different in situ hybridization and immunohistochemistry technologies, and is pushing the limits for multiplexing combinations of microRNA, RNA, DNA and proteins.

Take the opportunity to speak with Bioneer and Dr. Schnack-Nielsen at the event in Cambridge, or feel free to contact him by email or calling +45 45 160 444.

To register for the symposium, follow the link.
To download the flyer, press
here.
To learn more about Bioneer’s histology capabilities, press
here.

Last updated:
February 3, 2020

Bioneer

Bioneer A/S is an innovative research-based company providing services within biomedicine and biotechnology.

Click here to read more about us!
Get in touch with us!
Visit us

Bioneer A/S
Kogle Allé 2
DK-2970 Hørsholm
Denmark

Send us mail